EDITORIAL IRA

Dear All

Greetings for the new year. May it be filled with prosperity, health and happiness. In this issue, a “Puzzle of the Issue” has been introduced in the “Fellows’ Corner” for our inquisitive youth (replies will be suitably awarded!). Two practical learning points are included in the “Quarterly Highlights” section – addition of spine MRI to image scoring may not be worth it in spondyloarthritis and from the DRESS study, dose reduction of TNFi in RA patients may be possible without losing benefit. From the bench side, promoting myofibroblast apoptosis by using “mimetics” for the same may halt fibrosis in scleroderma, and from there possible interpolation to other fibrotic diseases! Procalcitonin – to order or not to order is the question and our “Clinical Pearl” clarifies that for you. Two new drugs from the industry desk and two delightful write-ups – one in the Patients’ Perspective by Dr. Suma Balan and one by Dr. Anu Desai in the Fellows’ Corner – are Must Read.

Read more

From the IRA

The OACON 2017

The First National Congress on Osteoarthritis (OACON 2017) was organized at Hotel Clarks Avadh, Lucknow, on September 23 and 24, 2017, under the chairmanship of Prof. Siddharth Das and Prof. G.K. Singh. Dr. Pooja Dhaon was the Organizing Secretary and Prof. R.N. Srivastava was the Scientific Chairman. It was the first conference on osteoarthritis (OA) in India, even though OA is the most common type of arthritis and is a more common occurrence than diabetes, blood pressure, and heart disease. Recently, the Government of India stated that OA is the fourth most common cause of disability in India, with a major economic burden on the society. The conference was organized under the aegis of Society for Osteoarthritis Research (SOAR), which is a charitable registered society working in the field of OA. The society has about 100 members, including rheumatologists, orthopedic surgeons, physicians, and basic scientists from all over India.

Read more

QUARTERLY HIGHLIGHTS

Dr C Balakrishnan, Consultant Rheumatologist, Hinduja hospital, Mumbai

Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: A longitudinal study in arthralgia during progression to clinical arthritis. Ann Rheum Dis. 2017 Oct;76(10):1751-1754.

Objective: Although anticitrullinated protein antibody (ACPA)-positive and ACPA-negative rheumatoid arthritis (RA) has different etiopathologies, the clinical presentation at the time of diagnosis is similar. This study evaluated whether there are phenotypic differences in the symptomatic pre-RA phase.

Methods: Patients with arthra lgia included in the Leiden clinically suspect arthralgia cohort who developed arthritis during follow-up were studied (n=67). Symptoms at symptom onset...

Read more

Patient's Perspective

Education and Empowerment Program for Patients

An innovative unique program for patients was organized by Dr. Danda and his team at Christian Medical College, Vellore. It was a 2-day program held on December 15 and 16, 2017. Around 250 patients and relatives of patients and 50 rheumatologists from various parts of the country attended the meet. The theme of the meet was Education for Self-care and Efforts for Empowerment. The meet had educative lectures by the faculty and interactive sessions with patients. Patients had their doubts cleared by experts. There were workshops on individual rheumatic diseases wherein the patients were taught about self-care and assessment of the disease. There were deliberations on how to monitor drug toxicity.

FELLOWS’ CORNER

Dr Shefali Sharma, Rheumatology, PGIMER, Chandigarh

A forgotten mode…

A 45-year-old female non-diabetic, non-hypertensive, hypothyroid patient on 75 µg of levothyroxine supplementation for the past 5 years presented to the Rheumatology OPD of PGIMER Chandigarh with complaints of gradually progressive blackish discoloration of tip of the left thumb and index finger for the past 20 days. It was associated with severe pain, disturbing her sleep, increasing on exposure to cold temperature. She had a similar episode during the previous winter, which had resolved with conservative management. She had no history of joint pains, skin tightening, oral ulcer, dysphagia, skin rash, alopecia, dryness of eyes or mouth, or family history of similar illness. She was started on conservative management in the form of vasodilatory therapy elsewhere, but her symptoms progressed to involve the distal phalanges of her thumb and index finger. In view of progression of symptoms, she was admitted to the hospital for Inj Alprostadil (PGE1) infusion. On clinical examination, all the peripheral pulses were equally palpable, and there was no blood pressure difference.

MY LIFE, MY TIMES

Interviewer: Dr Banwari Sharma, Interviewee: Dr Mahendranath

Que 1: What prompted you to take up rheumatology in your earlier days?

When I landed in the UK in 1978, it was a bad winter. I started working in acute medicine outside London. It had been very busy, with literally no time to study or relax. After 3–4 months, I decided to switch over to rheumatology as it was less stressful (I presumed). Even in 1978, rheumatology was neither a well-recognized nor a popular specialty in the UK. I decided to take up rheumatology as a career, and the prospect of being the first Rheumatologist of Karnataka was thrilling. I did work in some of the best rheumatology centers and with stalwarts. As I always wanted to come back to India, I returned in 1983 and started rheumatology practice in Bangalore.

Read more

Industry Desk

Apremilast- Plaque Psoriasis and Psoriatic Arthritis (PsA)

Apremilast is a small molecule inhibitor of PDE4, approved by the Food and Drug Administration in 2014, and now available in India for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. Its use in these patient populations has been assessed in two phase III clinical trial programs (ESTEEM in plaque psoriasis and PALACE I, II, and III in psoriatic arthritis).

Dosing Available in tablet form, and recommended doses are 30 mg twice daily following an up-titration at a rate of 10 mg daily over 6 days...

CLINICAL PEARLS

Pro calcitonin [PCT]: Pro-infection? Role in systemic Rheumatic diseases

Infections are one of the most common cause of morbidity and mortality in rheumatic diseases. Autoimmune disease and immunosuppression makes a patient more susceptible. Differentiating a disease flare from infection has always remained a challenge even with addition of more and more armamentorium. The two may have similar clinical and laboratory features, beside the fact that the infections may precipitate underlying rheumatic disease flare, adding to the dilemma. It may not always be possible to wait for cultures as the patient may not give enough time and the management of an infection versus disease flare is poles apart.

Procalcitonin, a 116 amino acid protein and a precursor of calcitonin, produced by parafollicular C cells of thyroid gland, usually undetectable in healthy individuals, for unknown reasons, is increased in patients with infections [1] Bacterial infections resulting in increased endotoxin and IL-1 beta stimulates PCT secretion whereas IFN- gamma tends to decrease it [4] Procalcitonin rises within 4 hours, peaks after 6 hours and plateaus between 8 to 24 hours. PCT has a half-life time of approximately 24 hours, independent of renal function[2].

Life is not All Medicine

African Safari

It was a clear bright day. We started early in the morning from the cottage we had taken right in the middle of the Savannah. We had moved in the night before to watch the animals, when they come out to graze. As soon as we entered the gate of the Safari, we were met by Giraffes feeding on the bushes. Soon two ostriches were seen chasing each other. Then the Wildebeests came out in herds. The zebras were seen in families, one foal was feeding, while the mare grazed nonchalantly, the proud stallion strutted about. I was beyond myself with excitement! I had never seen these animals before except on National Geographic channel on TV and here they were in flesh and blood, just meters away from me! My camera went click, click, click!!!

Read more